Regentis Biomaterials Ltd. Net Fee Amt
Regentis Biomaterials Ltd. (RGNT) had Net Fee Amt of $455.04 as of 2026-08-09, per its S-8 filed 2026-08-11.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-11
- 2026-08-09: Net Fee Amt $455.04.
- 2026-07-01: Net Fee Amt $2.25K.
- 2026-04-29: Net Fee Amt $1.69K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-09 | $455.04 S-8 · filed 2026-08-11 |
| 2026-07-01 | $2.25K F-1 · filed 2026-07-08 |
| 2026-04-29 | $1.69K F-1 · filed 2026-05-01 |